A fungi-derived cyclic peptide enhances Th9-mediated antitumor immunity by targeting ZAP70 and SREBP1
Open Access
- 2 December 2025
- journal article
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 136 (3)
Abstract
Adoptive cell therapy (ACT) relies on durable and functional T cells to mediate tumor clearance. Th9 cells are a metabolically fit CD4 + T cell subset with strong persistence but limited cytotoxicity. Here, we identified endomelipeptide A (EpA), a cyclic peptide isolated from Ganoderma lucidum –associated endophytic fungi, as a potent enhancer of Th9 cell differentiation. EpA promoted a cytotoxic Th9 phenotype with enhanced mitochondrial function and metabolic fitness. Mechanistically, EpA dually targeted ZAP70 and SREBP1, coupling T cell receptor signaling activation with lipid metabolism suppression. EpA-treated Th9 cells mediated robust, CD8 + T cell–dependent tumor control and enhanced the efficacy of human Th9 CAR T cell therapy in vivo. These findings establish EpA as a distinct cyclic peptide that reprograms Th9 cells and provides a potential approach to boost ACT efficacy.Keywords
Funding Information
- National Natural Science Foundation of China (82372775,82172709)
- Basic and Applied Basic Research Foundation of Guangdong Province (2023A1515012514)
- Guangzhou Key Research and Development Science Foundation (2023B1515120053)
This publication has 62 references indexed in Scilit:
- Functional diversity and regulation of IL-9-producing T cells in cancer immunotherapyCancer Letters, 2024
- Ad-hoc modifications of cyclic mimetics of SOCS1 protein: Structural and functional insightsEuropean Journal of Medicinal Chemistry, 2022
- Cyclic peptides nanospheres: A ‘2-in-1′ self-assembled delivery system for targeting nucleus and cytoplasmEuropean Journal of Pharmaceutical Sciences, 2022
- Blocking of the PD-1/PD-L1 interaction by a novel cyclic peptide inhibitor for cancer immunotherapyScience China Life Sciences, 2020
- Intratumoral CD4+ T Cells Mediate Anti-tumor Cytotoxicity in Human Bladder CancerCell, 2020
- A novel cyclic peptide targeting LAG-3 for cancer immunotherapy by activating antigen-specific CD8+ T cell responsesActa Pharmaceutica Sinica B, 2020
- Th9 Cells Represent a Unique Subset of CD4+ T Cells Endowed with the Ability to Eradicate Advanced TumorsCancer Cell, 2018
- Metabolic Regulation of T Cell Longevity and Function in Tumor ImmunotherapyCell Metabolism, 2017
- Mitochondrial Dynamics Controls T Cell Fate through Metabolic ProgrammingCell, 2016
- Production and Characterization of Surfactin-Type Lipopeptides as Bioemulsifiers Produced by a Pinctada martensii-Derived Bacillus mojavensis B0621AApplied Biochemistry and Biotechnology, 2015